Health Tech, or digital health, helps us understand and take control of our own health. But we also cover more traditional health news like medicines, vaccines and medical procedures.
Processes that previously required more than 50 people and took several months can now be handled by only three people with AI support. Novo Nordisk has reduced the time to compile regulatory documents from 15 weeks to less than 10 minutes using AI.
Scientists have for the first time managed to observe how a bacterium begins living inside a fungal cell. The results provide new understanding of how complex life has evolved.
Despite covid-19 variant XEC showing concerning early results in the laboratory, hospitalizations are fewer than previous winters. The majority of those infected are either asymptomatic or experience only mild cold symptoms that can be confused with seasonal allergies.
Alphabet's subsidiary Isomorphic Labs plans to have their first AI-designed drugs in clinical trials before the end of the year. The company focuses on major disease areas including cancer, cardiovascular diseases, and neurodegeneration.
Study with 215,000 participants shows that Ozempic-like drugs reduce the risk of 42 different health conditions. People taking the medications have a 12% lower risk of developing Alzheimer's disease. The study also shows 9% lower risk of heart attack and 8% lower risk of deep vein thrombosis.
David Baker uses AI's ability to generate hallucination to develop entirely new proteins for medical treatment. His team converts AI's imagined protein structures into real proteins that can be used in healthcare. The method has led to 10 million new proteins.
Childhood cancer mortality in the US has decreased six-fold since the 1950s. Improved treatment methods for leukemia have led to significantly more children surviving the disease. Mortality has decreased significantly for all types of cancer, including lymphoma and multiple myeloma.
Neko Health has secured an investment of $290 million to open more clinics in Europe and the USA. The company has already scanned 10,000 people and has 100,000 people on the waiting list.
A child with a deadly metabolic disease has been successfully treated with a new type of gene editing called ARCUS. The treatment allowed the child to stop their special diet after three months.